A multicenter phase II study of pazopanib in patients with advanced gastrointestinal stromal tumors (GIST) following failure of at least imatinib and sunitinib
Autor: | Ganjoo, K.N. *, Villalobos, V.M., Kamaya, A., Fisher, G.A., Butrynski, J.E., Morgan, J.A., Wagner, A.J., D'Adamo, D., McMillan, A., Demetri, G.D., George, S. |
---|---|
Zdroj: | In Annals of Oncology January 2014 25(1):236-240 |
Databáze: | ScienceDirect |
Externí odkaz: |